EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections

Stefano Salvatore, Alessandro Ferdinando Ruffolo, Guglielmo Stabile, Arianna Casiraghi, Gabriella Zito, Francesco De Seta

European Urology Focus · 2023

DOI: 10.1016/j.euf.2022.12.013 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Urology Focus, 2023. Verfasst von Stefano Salvatore und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan…. Hauptthemen laut MEDLINE: Bacteriuria, Urinary Tract Infections, Escherichia coli Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The rise in antimicrobial resistance means that alternative approaches for the treatment and prevention of urinary tract infection (UTIs) are required. OBJECTIVE: To evaluate the safety and efficacy of a D-mannose-based dietary supplement (D-mannose, citric acid, prebiotic fibers, Astragalus, and dandelion; DAPAD complex) for the treatment of uncomplicated acute E. coli UTIs. DESIGN, SETTING, AND PARTICIPANTS: This was a single-center, randomized, double-blind, placebo-controlled trial conducted from April 2021 to October 2021 in Rajalakshmi Hospital and Research Centre (Bangalore, India). The participants were nonmenopausal women with an acute uncomplicated E. coli UTI. UTI was diagnosed according to the presence of at least one urinary symptom and bacteriuria (>100 000 CFU/ml). INTERVENTION: The DAPAD complex was administered twice a day for 5 d, with phenazopyridine and alkalizing agents as the standard of care (SOC). The control group received placebo with SOC. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Subjective (clinical resolution/response) and objective (midstream bacteriuria) outcomes were evaluated at the end of therapy (day 6) and at day 35 of follow-up. Adverse events were recorded. Categorical variables were analyzed using χ2 and Fisher's exact tests; a p value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriuriaUrinary Tract InfectionsEscherichia coli InfectionsFemaleHumansMannoseEscherichia coliTreatment OutcomeIndiaDietary SupplementsPrebiotics

Stichwörter der Autor:innen

D-MannoseDietary supplementUrinary tract infection

Substanzen

MannosePrebiotics

Autor:innen und Institutionen

  • School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: alesruffolo@gmail.com.
  • Department of Medical, Surgical and Health Sciences, Institute for Maternal and Child Health, University of Trieste, IRCCS Burlo Garofolo, Trieste, Italy.

Zitieren

APA

Salvatore, S., Ruffolo, A. F., Stabile, G., Casiraghi, A., Zito, G., & De Seta, F. (2023). A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections. European Urology Focus. https://doi.org/10.1016/j.euf.2022.12.013

Vancouver

Salvatore S, Ruffolo AF, Stabile G, Casiraghi A, Zito G, De Seta F. A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections. European Urology Focus. 2023. doi:10.1016/j.euf.2022.12.013

BibTeX
@article{Salvatore2023,
  author = {Salvatore, Stefano and Ruffolo, Alessandro Ferdinando and Stabile, Guglielmo and Casiraghi, Arianna and Zito, Gabriella and De Seta, Francesco},
  title = {A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections},
  journal = {European Urology Focus},
  year = {2023},
  doi = {10.1016/j.euf.2022.12.013}
}
Kostenlos starten →